Molecular Pathology & Genomics

British Journal of Biomedical Science: second quarter 2022

Deputy Editor Dr Mark Hajjawi gives a round-up of the papers published over recent months.

AI potential for breast cancer screening

A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programmes.

Revolutionary thinking

Another step has been taken in the battle against antimicrobial resistance with the development of a synthetic antibiotic.

Eye scanner targets neurodegenerative diseases

In a large-scale EU project, the capabilities of optical coherence tomography (OCT) and Raman spectroscopy have been combined in a novel eye scanner. Using this, it is possible to add molecular information to the visualisation of the internal structure of the eye .

Expanding the target range of crispr/cas systems

US researchers have created genome editing technology that allows for variations in target DNA but retains local specificity.

My lab: A genomics unit in Wales

Joanne Watkins, Senior Biomedical Scientist and Deputy Head of Pathogen Genomics Unit, gives a guided tour of her laboratory in Cardiff.

Modelling behaviour

Computational modelling has “provided a window into the evolution of a tumour”. Biological physicist Xiao Fu explains what this means for our knowledge of cancer progression.

Precision surveillance of colorectal cancer

Some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilising precision medicine, have been revealed.

Top